Nucleic acid-based cancer biomarkers (NABCBs) have emerged as a notable and
continuously captivating research focal point within the domain of oncology. As a result …

Design and exploitation of high-property and multifunctional emitters for achieving
immobilization-free, label-free, enzyme-free, and dual-mode determination of microRNA …

Self-powered biofuel cells (BFCs) have evolved for highly sensitive detection of biomarkers
such as noncodon micro ribonucleic acids (miRNAs) in the presence of interfering …

Drug-induced liver injury (DILI) is a major challenge in clinical medicine and drug
development. There is a need for rapid diagnostic tests, ideally at point-of-care. MicroRNA …

MicroRNAs (miRNAs) are crucial regulators of gene expression at the post-transcriptional
level, offering valuable insights into disease mechanisms and prospects for targeted …

Procalcitonin (PCT) is a polypeptide produced by the parafollicular cells of the thyroid gland
and serves as a vital marker for the diagnosis and treatment of sepsis and other infectious …

With recent advances in point-of-care testing, wearable electronics, and implantable medical
devices, there is a growing interest in developing state-of-the-art methods to monitor human …

Combining heterojunctions and advanced structures is an effective strategy for improving
light capture capability and electron-hole pair separation of photoactive materials. In this …

MicroRNAs (miRNAs) hold immense potential as disease biomarkers, yet their short lengths
and high sequence homology pose unique challenges in detection. Conventional methods …

MicroRNAs are small ribonucleotides that act as key gene regulators. Their altered
expression is often associated with the onset and progression of several human diseases …